A Alqerban, SN Asiri, F Alharbi… - European Review for …, 2023 - europeanreview.org
OBJECTIVE: The aim of this study is to evaluate the effect of ten proinflammatory cytokines in GCF of participants with raised body mass index (BMI) compared to nonobese subjects …
AȘ Marghescu, S Vlăsceanu, M Preda, M Țigău… - Cancers, 2024 - mdpi.com
Simple Summary Pulmonary oncological issues are a significant public health concern, often complicated by the presence of other pulmonary conditions, which can complicate …
MC Radu, MS Armean, RD Chivu, J Aurelian… - Nursing Reports, 2024 - mdpi.com
Introduction: Pregnant women's experiences and concerns regarding childbirth are complex, necessitating a multidimensional and personalized approach in maternal care. This study …
C Sabino, P BERATE, S CANDREA… - Balneo and PRM …, 2021 - bioclima.ro
Introduction. The current treatment and prevention of oral disorders, dental caries, periodontal and gum diseases, follow a very non-specific control of plaque as the main …
Concerns about the health effects of sugary foods and drinks have led to an increased consumption of sugar-free alternatives. Artificial sweeteners, often hundreds of times …
VM Ruta, TG Alexescu, AR Ungur… - Journal of Mind and …, 2020 - scholar.valpo.edu
Lungs have long been considered sterile, but recent research has shown that a large number of microbiological organisms exist in the lungs of healthy subjects (including …
AD MAIEREAN, C TONCA, MG PERNE… - Balneo Research … - academia.edu
Chronic obstructive pulmonary disease (COPD) is a progressive disease characterized by dyspnea and chronic cough. The main risk factor is cigarette smoking, but there are other …
A MAIEREAN, MG PERNE, C TONCA… - Balneo Research …, 2020 - researchgate.net
Obstructive sleep apnea (OSA) has become a major worldwide health concern and affects 2- 4% of males and 1-2% females. In subjects diagnosed with mild or severe OSA, CPAP …
NS MOTOC, AD MAIEREAN, MA MAN, TG ALEXESCU… - lung cancer - bioclima.ro
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fatal lung disease with a median survival rate of 2-4 years after diagnosis, occurring primarily in older adults. The …